Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2009
10/20/2009US7605140 Endothelial growth factors; antiischemic agents; neovascularization
10/20/2009US7605133 Isolated peptides to treat alpha-synuclein diseases
10/20/2009US7605127 Truncated hepatocyte growth factor variant protein HGF/NK2
10/20/2009US7605115 Subtilisin variants
10/20/2009US7605000 Invention provides a DNA molecule capable of expressing a heterologous polypeptide under cold shock conditions, where the DNA molecule is preferably a self-replicating expression vector
10/20/2009US7604995 Compositions, kits, and methods for stimulation of homologous recombination
10/20/2009US7604994 Genetically altered antibody-producing cell lines with improved antibody characteristics
10/20/2009US7604989 Prevention or delaying apoptosis in recombinant cell; obtainceks transforme with nucleotide sequences coding antiapoptotic agents, express sequences, monitor adjustment in apotosis activity
10/20/2009US7604980 Protein expression system
10/20/2009US7604979 Method for producing an L-amino acid using a bacterium with an optimized level of gene expression
10/20/2009US7604976 Fragments of a plant genome; controlling the expression of a gene; tools for genetic mapping; recognizing or isolating identical or related DNA fragments; identification of a particular individual organism; clustering of a group of organisms with a common trait
10/20/2009US7604973 Lyases; bactericides; gene knockout; animal husbandry; use of nucleic acid segment in the preparation of recombinant cells which produce hyaluronate synthase and its hyaluronic acid product
10/20/2009US7604972 Nicotianamine synthase
10/20/2009US7604971 Sequence-determined DNA fragments encoding UBIE/COQ5 methyltransferase family proteins
10/20/2009US7604970 Variants of the PapM polypeptide of bacteria of the Streptomyces genus
10/20/2009US7604969 improved substrate specificity to glucose, amino acid sequence having the substitution, deletion, insertion or addition of one or more amino acid residues excluding amino acid 365 in the amino acid sequence
10/20/2009US7604962 α-agarase and process for producing the same
10/20/2009US7604961 VP1 of foot-and-mouth disease virus
10/20/2009US7604960 Transient protein expression methods
10/20/2009US7604959 Cell-based assays employing voltage and calcium dyes
10/20/2009US7604958 Transfection, culturing; electrophoresis
10/20/2009US7604936 Methods and compositions for diagnosis and monitoring auto immune and chronic inflammatory diseases
10/20/2009US7604931 Cripto mutant and uses thereof
10/20/2009US7604810 Conserved Neisserial antigens
10/20/2009US7604808 Circovirus sequences associated with piglet weight loss disease (PWD)
10/20/2009US7604805 Protein logic gates
10/20/2009US7604803 Codelivery to a cell of nucleic acid and assistor protein (antigen) where the nucleic acid encodes an antigenic protein or which shares an epitope(s) with the assistor protein; the nucleic acid is entrapped in liposome intravesicular space; assistor protein is on the liposome surface; synergistic
10/20/2009US7604800 Antibodies and their derivatives that induce apoptosis upon binding to P-Selectin Glycoprotein Ligand-1 (PSGL-1) on activatedT cells; autoimmune diseases, transplant rejection, antiallergens, and T cell-derived cancers, anticarinogenic agents;immunosuppressants; induction of immunological tolerance
10/20/2009US7604798 Methods and compositions for importing nucleic acids into cell nuclei
10/20/2009CA2392463C Novel use of uridine diphosphate glucose 4-epimerase
10/20/2009CA2384407C 2-azapurine compounds and their use
10/20/2009CA2376056C Mutant fatty acid desaturase and methods for directed mutagenesis
10/20/2009CA2359667C Method of identifying n-terminal probnp
10/20/2009CA2341354C Dengue viruses that are replication defective in mosquitos for use as vaccines
10/20/2009CA2330363C Diacylglycerol o-acyltransferase
10/20/2009CA2330183C Novel insulin analogs with enhanced zinc binding
10/20/2009CA2250085C Modulators of tnf receptor associated factor (traf), their preparation and use
10/20/2009CA2227467C Helper virus-free herpesvirus vector packaging system
10/15/2009WO2009126944A1 Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
10/15/2009WO2009126933A2 Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
10/15/2009WO2009126927A2 Methods of generating insulin-producing cells
10/15/2009WO2009126898A2 Humanized monoclonal antibodies that specifically bind and/or neutralize japanese encephalitis virus( (jev) and their use
10/15/2009WO2009126896A2 Methods and compositions for root knot nematode control
10/15/2009WO2009126890A2 Production of carotenoids in oleaginous yeast and fungi
10/15/2009WO2009126816A1 Production of ospa for lyme disease control
10/15/2009WO2009126726A1 Methods and compositions for diagnosing and modulating human papillomavirus (hpv)
10/15/2009WO2009126719A2 Commensal bacteria as signal mediators within a mammalian host
10/15/2009WO2009126655A2 Reprogramming a cell by inducing a pluripotent gene through use of a small molecule modulator
10/15/2009WO2009126651A2 Mat ii subunit rnai and therapeutic methods using same
10/15/2009WO2009126573A2 Use of virus-induced gene silencing (vigs) to down-regulate genes in plants
10/15/2009WO2009126563A1 Methods and compositions for the regulation of microrna processing
10/15/2009WO2009126470A2 Plant regulatory elements and uses thereof
10/15/2009WO2009126463A2 Filamentous fungi with inactivated protease genes for altered protein production
10/15/2009WO2009126462A2 Methods and compositions for improving plant health
10/15/2009WO2009126395A1 Method for identifying the sequence of one or more variant nucleotides in a nucleic acid molecule
10/15/2009WO2009126359A1 Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding lnt3 or lnt3-like polypeptides
10/15/2009WO2009126350A2 Methods and compositions for targeting polyubiquitin
10/15/2009WO2009126348A1 Viral compositions and methods
10/15/2009WO2009126251A2 Reprogramming a cell by inducing a pluripotent gene through use of an hdac modulator
10/15/2009WO2009126250A2 Reprogramming a cell by inducing a pluripotent gene through rna interference
10/15/2009WO2009126208A2 Heat resistant plants and plant tissues and methods and materials for making and using same
10/15/2009WO2009125992A2 Vector for transformation using transposons, microorganisms transformed by the vector, and method for producing l-lysine using the same
10/15/2009WO2009125986A2 Lyophilized dna formulations for enhanced expression of plasmid dna
10/15/2009WO2009125934A2 Pna probes, kits and methods for cytochrome p450 genotyping
10/15/2009WO2009125924A2 Mutant microorganism with high ability of producing putrescine and preparation of putrescine using same
10/15/2009WO2009125902A1 Adeno associated virus serotype five vector for targeted gene delivery
10/15/2009WO2009125826A1 Gene capable of being expressed specifically in endosperm of plant, promoter for the gene, and use of the gene and the promoter
10/15/2009WO2009125804A1 Screening method
10/15/2009WO2009125798A1 Method for screening of pharmaceutical candidate substance for treatment of cancer in which hedgehog pathway is activated
10/15/2009WO2009125646A1 Tdp-43-storing cell model
10/15/2009WO2009125626A1 Mesothelioma-specific promoter and use thereof
10/15/2009WO2009125607A1 Apoptosis inducer
10/15/2009WO2009125401A2 Compositions and methods for enhancing oil content in plants
10/15/2009WO2009125369A1 Heparanase deficient non-human mammals
10/15/2009WO2009125343A2 Method for producing selenoproteins
10/15/2009WO2009125231A2 Anti-atheroma vaccine
10/15/2009WO2009125179A1 Biological adjuvants
10/15/2009WO2009125042A1 Glycosylated indolecarbazoles, method for obtaining same and uses thereof
10/15/2009WO2009125006A2 Production of nucleic acid
10/15/2009WO2009124973A1 Inhibitors of stim1 for the treatment of cardiovascular disorders
10/15/2009WO2009124777A1 Cis-acting diversification activator and method for selective diversification of nucleic acids
10/15/2009WO2009124670A1 Methods involving ms4a12 and agents targeting ms4a12 for therapy, diagnosis and testing
10/15/2009WO2009124378A1 Chimeric anti-measles antibody
10/15/2009WO2009124362A1 Suppressor of the endogenous interferon- gamma
10/15/2009WO2009124341A1 Rna molecules and uses thereof
10/15/2009WO2009124333A1 Modified chaperonin 10 and prr signaling
10/15/2009WO2009102558A3 Aquaculture feed, products, and methods comprising beneficial fatty acids
10/15/2009WO2009100008A3 Genetic methods for speciating campylobacter
10/15/2009WO2009099942A3 Chemically modified oligonucleotides and uses thereof
10/15/2009WO2009095641A3 Enhanced plant growth
10/15/2009WO2009092035A3 Methods and compositions for the analysis of biological molecules
10/15/2009WO2009091972A3 Chemically modified oligonucleotides and small molecules for use in reducing micro rna activity levels and uses thereof
10/15/2009WO2009088998A3 Glycosylation in avians
10/15/2009WO2009085935A3 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
10/15/2009WO2009083958A8 Isolated polypeptides, polynucleotides useful for modifying water user efficiency, fertilizer use efficiency, biotic/abiotic stress tolerance, yield and biomass in plants
10/15/2009WO2009082488A3 Methods for creating and identifying functional rna interference elements
10/15/2009WO2009081136A3 Screening
10/15/2009WO2009079549A3 Inhibitors of bacterial nitric oxide synthase, and related screening methods
10/15/2009WO2009078687A3 Recombinant microorganism having an ability of using sucrose as a carbon source
10/15/2009WO2009077755A3 Latency associated protein construct with aggrecanase sensitive cleavage site